ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 6, June 2025 | pp. 210–220
DOI: 10.46882/AJIDR/148800
Article Type: Research Article
Title: Molecular epidemiology and antiviral susceptibility of herpes simplex virus type 2 isolates from patients with recurrent genital ulcers
Names of Authors: Tendai Moyo¹*, Sarah Jenkins², Vikram Deshmukh³
Authors’ Affiliations: ¹Department of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe. ²Department of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. ³Department of Dermatology, Seth GS Medical College, Mumbai, India.
Abstract: Herpes simplex virus type 2 is the predominant cause of recurrent genital ulcer disease and significantly facilitates HIV transmission. We characterized the prevalence, thymidine kinase gene mutations, and acyclovir susceptibility of herpes simplex virus isolates from patients with genital ulcers. Ulcer swabs from 250 patients were tested using multiplex real-time polymerase chain reaction and phenotypic plaque reduction assays. Herpes simplex virus type 2 was confirmed in 58.4 percent of lesions, while acyclovir resistance mutations were identified in 3.4 percent of isolates, predominantly among HIV-positive individuals with prior episodic therapy. Syndromic ulcer management guidelines should incorporate acyclovir and monitor immunocompromised patients for antiviral resistance.
Keywords: Herpes simplex virus, Genital ulcer disease, Acyclovir resistance, HIV co-infection, Sexually transmitted infections
Citation: Moyo T, Jenkins S, Deshmukh V (2025). Molecular epidemiology and antiviral susceptibility of herpes simplex virus type 2 isolates from patients with recurrent genital ulcers. African Journal of Infectious Diseases Research, 12(6): 210–220. DOI: 10.46882/AJIDR/148800
Manuscript Timeline: Received: May 05, 2025; Revised: June 06, 2025; Accepted: June 19, 2025; Published: June 30, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read